Skip to content
10-Q

Quarterly Report

GLOBAL IMMUNE TECHNOLOGIES INC.

0001144204-12-065203

← back to feed
Filed
Nov 28, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Jun 30, 2012 23.89M sh
Operating Cash Flow Q1 2012 · Jun 30, 2012 −$1.14M
Operating Cash Flow Q1 2012 · Jun 30, 2011 $0
Stockholders Equity Q1 2012 · Jun 30, 2012 −$925.77K
Current Liabilities Q1 2012 · Jun 30, 2012 $925.77K
Current Liabilities Q1 2012 · Mar 31, 2012 $915.44K
Sga Expense Q1 2012 · Jun 30, 2012 $336.24K
Sga Expense Q1 2012 · Jun 30, 2011 $0
Net Income Q1 2012 · Jun 30, 2012 −$2.42M
Net Income Q1 2012 · Jun 30, 2011 −$7.5K
Operating Income Q1 2012 · Jun 30, 2012 −$1.5M
Operating Income Q1 2012 · Jun 30, 2011 −$7.5K
Cash And Equivalents Q1 2012 · Jun 30, 2011 $0
Cash And Equivalents Q1 2012 · Mar 31, 2011 $0